Cerebrovascular disease/stroke

Citations 101-110 of 141 total displayed.

Past content (since May 1999):

Articles
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives. A Prospective Study

Kazuomi Kario, Thomas G. Pickering, Yuji Umeda, Satoshi Hoshide, Yoko Hoshide, Masato Morinari, Mitsunobu Murata, Toshio Kuroda, Joseph E. Schwartz, and Kazuyuki Shimada
Circulation published March 3, 2003, doi:10.1161/01.CIR.0000056521.67546.AA [Abstract]  

Articles
Isolated Ambulatory Hypertension Predicts Cardiovascular Morbidity in Elderly Men

Kristina Björklund, Lars Lind, Björn Zethelius, Bertil Andrén, and Hans Lithell
Circulation published February 17, 2003, doi:10.1161/01.CIR.0000054622.45012.12 [Abstract]  

Clinical Investigations and Reports
Blood Pressure, Risk of Ischemic Cerebrovascular and Ischemic Heart Disease, and Longevity in ₁-Antitrypsin Deficiency: The Copenhagen City Heart Study

Morten Dahl, Anne Tybjærg-Hansen, Henrik Sillesen, Gorm Jensen, Rolf Steffensen, and Børge G. Nordestgaard
Circulation 2003;107:747-752; published online before print as doi:10.1161/01.CIR.0000049642.20484.5D [Abstract] [Full text]  

Articles
Blood Pressure, Risk of Ischemic Cerebrovascular and Ischemic Heart Disease, and Longevity in ₁-Antitrypsin Deficiency. The Copenhagen City Heart Study

Morten Dahl, Anne Tybjærg-Hansen, Henrik Sillesen, Gorm Jensen, Rolf Steffensen, and Børge G. Nordestgaard
Circulation published January 20, 2003, doi:10.1161/01.CIR.0000049642.20484.5D [Abstract]  

Basic Science Reports
Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases

Zhao Zhong Chong, Jing-Qiong Kang, and Kenneth Maiese
Circulation 2002;106:2973-2979; published online before print as doi:10.1161/01.CIR.0000039103.58920.1F [Abstract] [Full text]  

AHA Special Reports
Task Force on Strategic Research Direction: Basic Science Subgroup Key Science Topics Report

Joseph Loscalzo, Robert Balaban, Lance B. Becker, Geoffrey S. Ginsburg, Vladimir C. Hachinski, John E. Hall, Donald D. Heistad, Leslie A. Leinwand, Claude J. Lenfant, Eduardo Marban, Eric N. Olson, and Stephen M. Schwartz
Circulation 2002;106:e149-161e, doi:10.1161/01.CIR.0000040842.08331.4E [Full text]  

AHA Special Reports
Task Force on Strategic Research Direction: Clinical Science Subgroup Key Science Topics Report

Robert Bonow, Edward B. Clark, Gregory D. Curfman, Alan Guttmacher, Martha N. Hill, D. Craig Miller, Aubrey R. Morrison, Robert J. Myerburg, Michael D. Schneider, Myron L. Weisfeldt, James T. Willerson, and James B. Young
Circulation 2002;106:e162-166e, doi:10.1161/01.CIR.0000040841.95213.24 [Full text]  

AHA Special Reports
Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup Key Science Topics Report

Lori Mosca, Donna K. Arnett, Kathleen Dracup, Barbara C. Hansen, Darwin R. Labarthe, James S. Marks, Karen A. Matthews, Thomas A. Pearson, William Weintraub, and Walter Wilson
Circulation 2002;106:e167-172e, doi:10.1161/01.CIR.0000040840.52188.13 [Full text]  

AHA Special Reports
Report of the American Heart Association Task Force on Strategic Research Direction: Executive Summary

Robert Roberts, Robert O. Bonow, Joseph Loscalzo, and Lori Mosca
Circulation 2002;106:2630-2632, doi:10.1161/01.CIR.0000037747.50168.9C [Full text]  

Articles
Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases

Zhao Zhong Chong, Jing-Qiong Kang, and Kenneth Maiese
Circulation published November 11, 2002, doi:10.1161/01.CIR.0000039103.58920.1F [Abstract]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15